{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:05:55Z","timestamp":1779462355123,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ80911"],"award-info":[{"award-number":["2025JJ80911"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47802-1","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:46:20Z","timestamp":1775904380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prediction model for the risk of relapse in psoriasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoxue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gufen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"47802_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke, W.-H. & Sch\u00f6n, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"47802_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","volume":"155","author":"L Dubertret","year":"2006","unstructured":"Dubertret, L. et al. European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey. Br. J. Dermatol. 155, 729\u2013736 (2006).","journal-title":"Br. J. Dermatol."},{"key":"47802_CR3","doi-asserted-by":"publisher","first-page":"585634","DOI":"10.3389\/fmed.2021.585634","volume":"8","author":"C Peng","year":"2021","unstructured":"Peng, C. et al. Epidemiological variations in the global burden of psoriasis, an analysis with trends from 1990 to 2017. Front. Med. 8, 585634 (2021).","journal-title":"Front. Med."},{"key":"47802_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita, J. et al. Psoriasis and comorbid diseases: Epidemiology. J. Am. Acad. Dermatol. 76, 377\u2013390 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"47802_CR5","unstructured":"World Health Organization. Global Report on Psoriasis. (2016)."},{"key":"47802_CR6","doi-asserted-by":"publisher","first-page":"adv42945","DOI":"10.2340\/actadv.v105.42945","volume":"105","author":"C Skayem","year":"2025","unstructured":"Skayem, C., Taieb, C., Halioua, B., Baissac, C. & Saint Aroman, M. Epidemiology of psoriasis: A worldwide global study. Acta Derm Venereol 105, adv42945 (2025).","journal-title":"Acta Derm Venereol"},{"key":"47802_CR7","doi-asserted-by":"publisher","first-page":"880201","DOI":"10.3389\/fimmu.2022.880201","volume":"13","author":"J Bu","year":"2022","unstructured":"Bu, J., Ding, R., Zhou, L., Chen, X. & Shen, E. Epidemiology of psoriasis and comorbid diseases: A narrative review. Front. Immunol. 13, 880201 (2022).","journal-title":"Front. Immunol."},{"key":"47802_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/eurheartj\/ehac180","volume":"43","author":"J Cadrin-Tourigny","year":"2022","unstructured":"Cadrin-Tourigny, J. et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 43, e1\u2013e9 (2022).","journal-title":"Eur. Heart J."},{"key":"47802_CR9","doi-asserted-by":"publisher","first-page":"2480743","DOI":"10.1080\/09546634.2025.2480743","volume":"36","author":"S Huang","year":"2025","unstructured":"Huang, S., Bai, Y., Qi, R., Yu, H. & Duan, X. Personalized prediction of psoriasis relapse post-biologic discontinuation: A machine learning-driven population cohort study. J. Dermatolog. Treat. 36, 2480743 (2025).","journal-title":"J. Dermatolog. Treat."},{"key":"47802_CR10","doi-asserted-by":"publisher","first-page":"1488096","DOI":"10.3389\/fmed.2024.1488096","volume":"11","author":"S Huang","year":"2024","unstructured":"Huang, S., Chen, B., Qi, Y., Duan, X. & Bai, Y. Development and external validation of a prediction model for the risk of relapse in psoriasis after discontinuation of biologics. Front. Med. 11, 1488096 (2024).","journal-title":"Front. Med."},{"key":"47802_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s13555-023-01014-x","volume":"13","author":"G Girolomoni","year":"2023","unstructured":"Girolomoni, G. et al. Increasing access to effective systemic treatments in patients with moderate-to-severe psoriasis: Narrative review. Dermatol. Ther. 13, 2171\u20132185 (2023).","journal-title":"Dermatol. Ther."},{"key":"47802_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/ijd.17236","volume":"63","author":"V Wan","year":"2024","unstructured":"Wan, V. et al. Disparities and barriers to the access of biologics in moderate-to-severe adult psoriasis. Int. J. Dermatol. 63, 1293\u20131301 (2024).","journal-title":"Int. J. Dermatol."},{"key":"47802_CR13","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ 350, g7594 (2015).","journal-title":"BMJ"},{"key":"47802_CR14","first-page":"573","volume":"56","author":"Committee on Psoriasis, Chinese Society of Dermatology","year":"2023","unstructured":"Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China (2023 edition). Chin. J. Dermatol. 56, 573\u2013625 (2023).","journal-title":"Chin. J. Dermatol."},{"key":"47802_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley, R. D. et al. Calculating the sample size required for developing a clinical prediction model. BMJ 368, m441 (2020).","journal-title":"BMJ"},{"key":"47802_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13555-019-0310-5","volume":"9","author":"Y-W Huang","year":"2019","unstructured":"Huang, Y.-W. & Tsai, T.-F. Remission duration and long-term outcomes in patients with moderate-to-severe psoriasis treated by biologics or tofacitinib in controlled clinical trials: A 15-year single-center experience. Dermatol. Ther. 9, 553\u2013569 (2019).","journal-title":"Dermatol. Ther."},{"key":"47802_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","volume":"154","author":"L Francis","year":"2024","unstructured":"Francis, L., Capon, F., Smith, C. H., Haniffa, M. & Mahil, S. K. Inflammatory memory in psoriasis: From remission to relapse. J. Allergy Clin. Immunol. 154, 42\u201350 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"47802_CR18","first-page":"18","volume":"102","author":"EB Lee","year":"2018","unstructured":"Lee, E. B., Wu, K. K., Lee, M. P., Bhutani, T. & Wu, J. J. Psoriasis risk factors and triggers. Cutis 102, 18\u201320 (2018).","journal-title":"Cutis"},{"key":"47802_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","volume":"45","author":"L-J Zhang","year":"2016","unstructured":"Zhang, L.-J. et al. Antimicrobial peptide LL37 and MAVS signaling drive interferon-\u03b2 production by epidermal keratinocytes during skin injury. Immunity 45, 119\u2013130 (2016).","journal-title":"Immunity"},{"key":"47802_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","volume":"22","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Triggers for the onset and relapse of psoriasis: a review and update. Cell Commun. Signal 22, 108 (2024).","journal-title":"Cell Commun. Signal"},{"key":"47802_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/ijd.13956","volume":"57","author":"TJ Stewart","year":"2018","unstructured":"Stewart, T. J., Tong, W. & Whitfeld, M. J. The associations between psychological stress and psoriasis: A systematic review. Int. J. Dermatol. 57, 1275\u20131282 (2018).","journal-title":"Int. J. Dermatol."},{"key":"47802_CR22","first-page":"39","volume":"14","author":"L Potestio","year":"2024","unstructured":"Potestio, L. et al. Risk factors for psoriasis flares: A narrative review. Psoriasis (Auckl) 14, 39\u201350 (2024).","journal-title":"Psoriasis (Auckl)"},{"key":"47802_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbrc.2019.03.185","volume":"513","author":"H Yang","year":"2019","unstructured":"Yang, H., Li, X., Zhang, L., Xue, F. & Zheng, J. Immunomodulatory effects of sleep deprivation at different timing of psoriasiform process on skin inflammation. Biochem. Biophys. Res. Commun. 513, 452\u2013459 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"47802_CR24","first-page":"788","volume":"96","author":"RH Thorleifsdottir","year":"2016","unstructured":"Thorleifsdottir, R. H. et al. Throat Infections are associated with exacerbation in a substantial proportion of patients with chronic plaque psoriasis. Acta Derm. Venereol. 96, 788\u2013791 (2016).","journal-title":"Acta Derm. Venereol."},{"key":"47802_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2249.2004.00600.x","volume":"138","author":"A Johnston","year":"2004","unstructured":"Johnston, A., Gudjonsson, J. E., Sigmundsdottir, H., Love, T. J. & Valdimarsson, H. Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells. Clin. Exp. Immunol. 138, 83\u201393 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"47802_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1172\/JCI6835","volume":"104","author":"JB Travers","year":"1999","unstructured":"Travers, J. B. et al. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J. Clin. Investig. 104, 1181\u20131189 (1999).","journal-title":"J. Clin. Investig."},{"key":"47802_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040769","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi, A., Gisondi, P., Bellinato, F. & Girolomoni, G. Immune response to vaccination in patients with psoriasis treated with systemic therapies. Vaccines https:\/\/doi.org\/10.3390\/vaccines8040769 (2020).","journal-title":"Vaccines"},{"key":"47802_CR28","first-page":"261","volume":"15","author":"F Shen","year":"2025","unstructured":"Shen, F. et al. Tobacco smoking was positively associated with disease relapse at week 24 and 48 among patients with psoriasis vulgaris in Shanghai: A prospective study. Psoriasis (Auckl) 15, 261\u2013272 (2025).","journal-title":"Psoriasis (Auckl)"},{"key":"47802_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaad.2017.04.015","volume":"77","author":"EJ Lee","year":"2017","unstructured":"Lee, E. J., Han, K. D., Han, J. H. & Lee, J. H. Smoking and risk of psoriasis: A nationwide cohort study. J. Am. Acad. Dermatol. 77, 573\u2013575 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"47802_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1365-2133.2011.10526.x","volume":"165","author":"AW Armstrong","year":"2011","unstructured":"Armstrong, A. W., Armstrong, E. J., Fuller, E. N., Sockolov, M. E. & Voyles, S. V. Smoking and pathogenesis of psoriasis: A review of oxidative, inflammatory and genetic mechanisms. Br. J. Dermatol. 165, 1162\u20131168 (2011).","journal-title":"Br. J. Dermatol."},{"key":"47802_CR31","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1016\/j.jaad.2005.10.029","volume":"54","author":"W Carey","year":"2006","unstructured":"Carey, W. et al. Relapse, rebound, and psoriasis adverse events: An advisory group report. J. Am. Acad. Dermatol. 54, S171-181 (2006).","journal-title":"J. Am. Acad. Dermatol."},{"key":"47802_CR32","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/bjd.16667","volume":"179","author":"MT Svendsen","year":"2018","unstructured":"Svendsen, M. T. et al. A smartphone application supporting patients with psoriasis improves adherence to topical treatment: A randomized controlled trial. Br. J. Dermatol. 179, 1062\u20131071 (2018).","journal-title":"Br. J. Dermatol."},{"key":"47802_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong, A. W., Harskamp, C. T. & Armstrong, E. J. Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis. JAMA Dermatol. 149, 84\u201391 (2013).","journal-title":"JAMA Dermatol."},{"key":"47802_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.23736\/S0026-4806.24.09570-3","volume":"116","author":"DA De Luca","year":"2025","unstructured":"De Luca, D. A., Papara, C., Hawro, T. & Tha\u00e7i, D. Psoriasis and diabetes: A review of the pathophysiological and therapeutic interconnections. Minerva Med. 116, 195\u2013222 (2025).","journal-title":"Minerva Med."},{"key":"47802_CR35","unstructured":"World Health Organization. Obesity and overweight. https:\/\/www.who.int\/news-room\/fa-ct-sheets\/detail\/obesity-and-overweight (2025)."},{"key":"47802_CR36","doi-asserted-by":"publisher","first-page":"e15685","DOI":"10.1111\/dth.15685","volume":"35","author":"ML Musumeci","year":"2022","unstructured":"Musumeci, M. L., Nasca, M. R., Boscaglia, S. & Micali, G. The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions. Dermatol. Ther. 35, e15685 (2022).","journal-title":"Dermatol. Ther."},{"key":"47802_CR37","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","volume":"10","author":"M Kunz","year":"2019","unstructured":"Kunz, M., Simon, J. C. & Saalbach, A. Psoriasis: Obesity and fatty acids. Front. Immunol. 10, 1807 (2019).","journal-title":"Front. Immunol."},{"key":"47802_CR38","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s40257-024-00887-8","volume":"25","author":"Y-H Huang","year":"2024","unstructured":"Huang, Y.-H. et al. Predicting the time to relapse following withdrawal from different biologics in patients with psoriasis who responded to therapy: A 12-year multicenter cohort study. Am. J. Clin. Dermatol. 25, 997\u20131008 (2024).","journal-title":"Am. J. Clin. Dermatol."},{"key":"47802_CR39","doi-asserted-by":"publisher","first-page":"103530","DOI":"10.1016\/j.autrev.2024.103530","volume":"23","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: An analysis of current evidence. Autoimmun. Rev. 23, 103530 (2024).","journal-title":"Autoimmun. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47802-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T14:21:56Z","timestamp":1779459716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47802-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47802"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47802-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8777210\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15999"}}